English

INTERPACE BIOSCIENCES, INC.

EDGAR

IDXG Current report (8-K) · filed 2026-10-15

Annual consolidated revenue for 2025: about USD 38.73M, using the latest reported figures. The previous period, 2024, was about USD 46.93M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

9.13 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 9131000 USD Source

Operating margin

3.52%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 321000 USD Source
Revenue: 9131000 USD Source

Operating cash flow

98 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 381000 USD Source
Operating Cash Flow: 283000 USD Source

Free cash flow

41 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 381000 USD Source
Operating Cash Flow: 283000 USD Source
Capital Expenditure: 198000 USD Source
Capital Expenditure: 141000 USD Source

Cash and cash equivalents: 2.7 million USD 2026-06-30 Source
Exact value

2700000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 27.7 million shares 2026-06-30 Source
Exact value

27700904 shares

Reported share-count change

526.28% · 23.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

4423093 shares · 2025-06-30· Source
27700904 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-15.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-17.5%

Prior period

USD 46.93 million

2024-01-01 – 2024-12-31
Current period

USD 38.73 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

38728000 − 46926000 = -8198000 USD

46926000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
38728000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Year-over-year change in Revenue: -8198000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 38728000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#819847 Filing: 000149315226013646 Input fundies:Revenue: 46926000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#820324 Filing: 000149315226013646
The citation records this snapshot. The page link may show a newer release later.
Net income
+266.7%

Prior period

USD 6.7 million

2024-01-01 – 2024-12-31
Current period

USD 24.58 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

24575000 − 6702000 = 17873000 USD

6702000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
24575000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Year-over-year change in Net income: 17873000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 24575000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#933597 Filing: 000149315226013646 Input fundies:NetIncome: 6702000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#934036 Filing: 000149315226013646
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+25.5%

Prior period

USD 4.65 million

2024-01-01 – 2024-12-31
Current period

USD 5.83 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

5831000 − 4646000 = 1185000 USD

4646000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
5831000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Year-over-year change in Operating cash flow: 1185000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5831000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#953293 Filing: 000149315226013646 Input fundies:OperatingCashFlow: 4646000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#953826 Filing: 000149315226013646
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-59.4%

Prior period

USD 876,000

2024-01-01 – 2024-12-31
Current period

USD 356,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

356000 − 876000 = -520000 USD

876000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
356000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Year-over-year change in Capital expenditure: -520000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 356000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#955904 Filing: 000149315226013646 Input fundies:CapitalExpenditure: 876000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#956431 Filing: 000149315226013646
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 38.73 million 100% of revenue
Cost of revenue USD 14.6 million 38% of revenue
Operating expenses USD 20.05 million 52% of revenue
Operating income USD 4.08 million 11% of revenue
Tax, interest and other Derived −USD 20.49 million −53% of revenue
Net income USD 24.58 million 63% of revenue

Cash

Operating cash flow USD 5.83 million 15% of revenue
Capital expenditure USD 356,000 0.9% of revenue
Free cash flow Derived USD 5.48 million 14% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 149% of revenue.
2017 Operating loss: operating costs were 140% of revenue.
2018 Operating loss: operating costs were 158% of revenue.
2019 Operating loss: operating costs were 209% of revenue.
2020 Operating loss: operating costs were 180% of revenue.
2021 Operating loss: operating costs were 177% of revenue.
2022 Operating loss: operating costs were 111% of revenue.
2023 90%
2024 14%83%
2025 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	13085000	19527000 Derived	-6442000	15561000 Derived	-22003000	Unavailable	Source 2016-01-01 – 2016-12-31: 13085000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -6442000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -22003000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -7607000 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	15897000	22190000 Derived	-6293000	-18846000 Derived	12553000	-15292000 Derived	Source 2017-01-01 – 2017-12-31: 15897000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6293000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 12553000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -15263000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 29000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	21896000	34529000 Derived	-12633000	70000 Derived	-12703000	-9122000 Derived	Source 2018-01-01 – 2018-12-31: 21896000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -12633000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -12703000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -8673000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 449000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	24220000	50656000 Derived	-26436000	304000 Derived	-26740000	-19088000 Derived	Source 2019-01-01 – 2019-12-31: 24220000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -26436000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -26740000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -18957000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 131000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	32398000	58464000 Derived	-26066000	385000 Derived	-26451000	-15554000 Derived	Source 2020-01-01 – 2020-12-31: 32398000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -26066000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -26451000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -13979000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1575000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	8197000	14533000 Derived	-6336000	8607000 Derived	-14943000	-9073000 Derived	Source 2021-01-01 – 2021-12-31: 8197000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -6336000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -14943000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -8719000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 354000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	31838000	35455000 Derived	-3617000	18341000 Derived	-21958000	-8014000 Derived	Source 2022-01-01 – 2022-12-31: 31838000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -3617000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -21958000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -7692000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 322000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	40036000	36080000 Derived	3956000	2002000 Derived	1954000	3319000 Derived	Source 2023-01-01 – 2023-12-31: 40036000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 3956000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 1954000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 3789000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 470000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	46926000	38818000 Derived	8108000	1406000 Derived	6702000	3770000 Derived	Source 2024-01-01 – 2024-12-31: 46926000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 8108000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 6702000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 4646000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 876000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	38728000	34644000 Derived	4084000	-20491000 Derived	24575000	5475000 Derived	Source 2025-01-01 – 2025-12-31: 38728000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 4084000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 24575000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 5831000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 356000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 38.7M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	13085000	Revenue: 13085000 Open source
20172017-12-31	Revenue	15897000	Revenue: 15897000 Open source
20182018-12-31	Revenue	21896000	Revenue: 21896000 Open source
20192019-12-31	Revenue	24220000	Revenue: 24220000 Open source
20202020-12-31	Revenue	32398000	Revenue: 32398000 Open source
20212021-12-31	Revenue	8197000	Revenue: 8197000 Open source
20222022-12-31	Revenue	31838000	Revenue: 31838000 Open source
20232023-12-31	Revenue	40036000	Revenue: 40036000 Open source
20242024-12-31	Revenue	46926000	Revenue: 46926000 Open source
20252025-12-31	Revenue	38728000	Revenue: 38728000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-17.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	38.7%	Revenue: 13085000 Open source Revenue: 9432000 Open source
20172017-12-31	Year over year	21.5%	Revenue: 15897000 Open source Revenue: 13085000 Open source
20182018-12-31	Year over year	37.7%	Revenue: 21896000 Open source Revenue: 15897000 Open source
20192019-12-31	Year over year	10.6%	Revenue: 24220000 Open source Revenue: 21896000 Open source
20202020-12-31	Year over year	33.8%	Revenue: 32398000 Open source Revenue: 24220000 Open source
20212021-12-31	Year over year	-74.7%	Revenue: 8197000 Open source Revenue: 32398000 Open source
20222022-12-31	Year over year	288.4%	Revenue: 31838000 Open source Revenue: 8197000 Open source
20232023-12-31	Year over year	25.7%	Revenue: 40036000 Open source Revenue: 31838000 Open source
20242024-12-31	Year over year	17.2%	Revenue: 46926000 Open source Revenue: 40036000 Open source
20252025-12-31	Year over year	-17.5%	Revenue: 38728000 Open source Revenue: 46926000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.5% 2025

Net margin 63.5% 2025

Free cash flow margin 14.1% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-49.2%	Operating Income: -6442000 Open source Revenue: 13085000 Open source
20172017-12-31	Operating margin	-39.6%	Operating Income: -6293000 Open source Revenue: 15897000 Open source
20182018-12-31	Operating margin	-57.7%	Operating Income: -12633000 Open source Revenue: 21896000 Open source
20192019-12-31	Operating margin	-109.1%	Operating Income: -26436000 Open source Revenue: 24220000 Open source
20202020-12-31	Operating margin	-80.5%	Operating Income: -26066000 Open source Revenue: 32398000 Open source
20212021-12-31	Operating margin	-77.3%	Operating Income: -6336000 Open source Revenue: 8197000 Open source
20222022-12-31	Operating margin	-11.4%	Operating Income: -3617000 Open source Revenue: 31838000 Open source
20232023-12-31	Operating margin	9.9%	Operating Income: 3956000 Open source Revenue: 40036000 Open source
20242024-12-31	Operating margin	17.3%	Operating Income: 8108000 Open source Revenue: 46926000 Open source
20252025-12-31	Operating margin	10.5%	Operating Income: 4084000 Open source Revenue: 38728000 Open source
20162016-12-31	Net margin	-168.2%	Net Income: -22003000 Open source Revenue: 13085000 Open source
20172017-12-31	Net margin	79%	Net Income: 12553000 Open source Revenue: 15897000 Open source
20182018-12-31	Net margin	-58%	Net Income: -12703000 Open source Revenue: 21896000 Open source
20192019-12-31	Net margin	-110.4%	Net Income: -26740000 Open source Revenue: 24220000 Open source
20202020-12-31	Net margin	-81.6%	Net Income: -26451000 Open source Revenue: 32398000 Open source
20212021-12-31	Net margin	-182.3%	Net Income: -14943000 Open source Revenue: 8197000 Open source
20222022-12-31	Net margin	-69%	Net Income: -21958000 Open source Revenue: 31838000 Open source
20232023-12-31	Net margin	4.9%	Net Income: 1954000 Open source Revenue: 40036000 Open source
20242024-12-31	Net margin	14.3%	Net Income: 6702000 Open source Revenue: 46926000 Open source
20252025-12-31	Net margin	63.5%	Net Income: 24575000 Open source Revenue: 38728000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 13085000 Open source Operating Cash Flow: -7607000 Open source
20172017-12-31	Free cash flow margin	-96.2%	Revenue: 15897000 Open source Operating Cash Flow: -15263000 Open source Capital Expenditure: 29000 Open source
20182018-12-31	Free cash flow margin	-41.7%	Revenue: 21896000 Open source Operating Cash Flow: -8673000 Open source Capital Expenditure: 449000 Open source
20192019-12-31	Free cash flow margin	-78.8%	Revenue: 24220000 Open source Operating Cash Flow: -18957000 Open source Capital Expenditure: 131000 Open source
20202020-12-31	Free cash flow margin	-48%	Revenue: 32398000 Open source Operating Cash Flow: -13979000 Open source Capital Expenditure: 1575000 Open source
20212021-12-31	Free cash flow margin	-110.7%	Revenue: 8197000 Open source Operating Cash Flow: -8719000 Open source Capital Expenditure: 354000 Open source
20222022-12-31	Free cash flow margin	-25.2%	Revenue: 31838000 Open source Operating Cash Flow: -7692000 Open source Capital Expenditure: 322000 Open source
20232023-12-31	Free cash flow margin	8.3%	Revenue: 40036000 Open source Operating Cash Flow: 3789000 Open source Capital Expenditure: 470000 Open source
20242024-12-31	Free cash flow margin	8%	Revenue: 46926000 Open source Operating Cash Flow: 4646000 Open source Capital Expenditure: 876000 Open source
20252025-12-31	Free cash flow margin	14.1%	Revenue: 38728000 Open source Operating Cash Flow: 5831000 Open source Capital Expenditure: 356000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 5.8M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-7607000	Operating Cash Flow: -7607000 Open source
20172017-12-31	Operating cash flow	-15263000	Operating Cash Flow: -15263000 Open source
20182018-12-31	Operating cash flow	-8673000	Operating Cash Flow: -8673000 Open source
20192019-12-31	Operating cash flow	-18957000	Operating Cash Flow: -18957000 Open source
20202020-12-31	Operating cash flow	-13979000	Operating Cash Flow: -13979000 Open source
20212021-12-31	Operating cash flow	-8719000	Operating Cash Flow: -8719000 Open source
20222022-12-31	Operating cash flow	-7692000	Operating Cash Flow: -7692000 Open source
20232023-12-31	Operating cash flow	3789000	Operating Cash Flow: 3789000 Open source
20242024-12-31	Operating cash flow	4646000	Operating Cash Flow: 4646000 Open source
20252025-12-31	Operating cash flow	5831000	Operating Cash Flow: 5831000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 5.5M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7607000 Open source
20172017-12-31	Free cash flow	-15292000	Operating Cash Flow: -15263000 Open source Capital Expenditure: 29000 Open source
20182018-12-31	Free cash flow	-9122000	Operating Cash Flow: -8673000 Open source Capital Expenditure: 449000 Open source
20192019-12-31	Free cash flow	-19088000	Operating Cash Flow: -18957000 Open source Capital Expenditure: 131000 Open source
20202020-12-31	Free cash flow	-15554000	Operating Cash Flow: -13979000 Open source Capital Expenditure: 1575000 Open source
20212021-12-31	Free cash flow	-9073000	Operating Cash Flow: -8719000 Open source Capital Expenditure: 354000 Open source
20222022-12-31	Free cash flow	-8014000	Operating Cash Flow: -7692000 Open source Capital Expenditure: 322000 Open source
20232023-12-31	Free cash flow	3319000	Operating Cash Flow: 3789000 Open source Capital Expenditure: 470000 Open source
20242024-12-31	Free cash flow	3770000	Operating Cash Flow: 4646000 Open source Capital Expenditure: 876000 Open source
20252025-12-31	Free cash flow	5475000	Operating Cash Flow: 5831000 Open source Capital Expenditure: 356000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

33.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	140.2%	Total Liabilities: 35247000 Open source Total Assets: 25136000 Open source
20172017-12-31	Liabilities / assets	37.5%	Total Liabilities: 13729000 Open source Total Assets: 36619000 Open source
20182018-12-31	Liabilities / assets	50.4%	Total Liabilities: 15681000 Open source Total Assets: 31127000 Open source
20192019-12-31	Liabilities / assets	57.9%	Total Liabilities: 29847000 Open source Total Assets: 51540000 Open source
20202020-12-31	Liabilities / assets	61.8%	Total Liabilities: 28228000 Open source Total Assets: 45681000 Open source
20212021-12-31	Liabilities / assets	89.3%	Total Liabilities: 34309000 Open source Total Assets: 38427000 Open source
20222022-12-31	Liabilities / assets	203.5%	Total Liabilities: 32515000 Open source Total Assets: 15979000 Open source
20232023-12-31	Liabilities / assets	168.6%	Total Liabilities: 22119000 Open source Total Assets: 13116000 Open source
20242024-12-31	Liabilities / assets	115%	Total Liabilities: 17009000 Open source Total Assets: 14792000 Open source
20252025-12-31	Liabilities / assets	33.9%	Total Liabilities: 11475000 Open source Total Assets: 33838000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.94× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	0.26×	Current Assets: 4240000 Open source Current Liabilities: 16241000 Open source
20172017-12-31	Current assets / current liabilities	2.45×	Current Assets: 19808000 Open source Current Liabilities: 8091000 Open source
20182018-12-31	Current assets / current liabilities	2.04×	Current Assets: 17721000 Open source Current Liabilities: 8669000 Open source
20192019-12-31	Current assets / current liabilities	0.95×	Current Assets: 16510000 Open source Current Liabilities: 17292000 Open source
20202020-12-31	Current assets / current liabilities	0.77×	Current Assets: 14122000 Open source Current Liabilities: 18233000 Open source
20212021-12-31	Current assets / current liabilities	0.78×	Current Assets: 12166000 Open source Current Liabilities: 15682000 Open source
20222022-12-31	Current assets / current liabilities	0.85×	Current Assets: 12154000 Open source Current Liabilities: 14283000 Open source
20232023-12-31	Current assets / current liabilities	0.91×	Current Assets: 10417000 Open source Current Liabilities: 11436000 Open source
20242024-12-31	Current assets / current liabilities	1.11×	Current Assets: 11773000 Open source Current Liabilities: 10615000 Open source
20252025-12-31	Current assets / current liabilities	1.94×	Current Assets: 9900000 Open source Current Liabilities: 5103000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 22 million Exact value Exact value: -22003000 USD 2016-01-01 – 2016-12-31: -22003000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2016-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: -22003000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22003000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#322706 Filing: 000149315221001330 The citation records this snapshot. The page link may show a newer release later.	−USD 7.61 million Exact value Exact value: -7607000 USD 2016-01-01 – 2016-12-31: -7607000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2016-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -7607000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7607000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315218003786/idxg-20171231.xml#1243406 Filing: 000149315218003786 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	USD 12.55 million Exact value Exact value: 12553000 USD 2017-01-01 – 2017-12-31: 12553000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2017-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: 12553000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12553000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#321748 Filing: 000149315221001330 The citation records this snapshot. The page link may show a newer release later.	−USD 15.26 million Exact value Exact value: -15263000 USD 2017-01-01 – 2017-12-31: -15263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2017-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -15263000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15263000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315219003733/idxg-20181231.xml#572878 Filing: 000149315219003733 The citation records this snapshot. The page link may show a newer release later.	USD 29,000 Exact value Exact value: 29000 USD 2017-01-01 – 2017-12-31: 29000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2017-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 29000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315219003733/idxg-20181231.xml#575721 Filing: 000149315219003733 The citation records this snapshot. The page link may show a newer release later.	−USD 15.29 million Calculation and evidence -15263000 − 29000 USD Exact free cash flow: -15292000 USD 2017-01-01 – 2017-12-31: -15263000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 29000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2017-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: -15292000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15263000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315219003733/idxg-20181231.xml#572878 Filing: 000149315219003733 Input fundies:CapitalExpenditure: 29000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315219003733/idxg-20181231.xml#575721 Filing: 000149315219003733 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 12.7 million Exact value Exact value: -12703000 USD 2018-01-01 – 2018-12-31: -12703000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2018-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: -12703000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12703000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#319643 Filing: 000149315221001330 The citation records this snapshot. The page link may show a newer release later.	−USD 8.67 million Exact value Exact value: -8673000 USD 2018-01-01 – 2018-12-31: -8673000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2018-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -8673000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8673000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#450877 Filing: 000149315221001330 The citation records this snapshot. The page link may show a newer release later.	USD 449,000 Exact value Exact value: 449000 USD 2018-01-01 – 2018-12-31: 449000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2018-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 449000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 449000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#420647 Filing: 000149315221001330 The citation records this snapshot. The page link may show a newer release later.	−USD 9.12 million Calculation and evidence -8673000 − 449000 USD Exact free cash flow: -9122000 USD 2018-01-01 – 2018-12-31: -8673000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 449000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2018-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: -9122000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8673000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#450877 Filing: 000149315221001330 Input fundies:CapitalExpenditure: 449000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221001330/idxg-20191231.xml#420647 Filing: 000149315221001330 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 26.74 million Exact value Exact value: -26740000 USD 2019-01-01 – 2019-12-31: -26740000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2019-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: -26740000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26740000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221030511/forms-1.htm#2381354 Filing: 000149315221030511 The citation records this snapshot. The page link may show a newer release later.	−USD 18.96 million Exact value Exact value: -18957000 USD 2019-01-01 – 2019-12-31: -18957000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2019-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -18957000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18957000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221030511/forms-1.htm#2400541 Filing: 000149315221030511 The citation records this snapshot. The page link may show a newer release later.	USD 131,000 Exact value Exact value: 131000 USD 2019-01-01 – 2019-12-31: 131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2019-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 131000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 131000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221030511/forms-1.htm#2403253 Filing: 000149315221030511 The citation records this snapshot. The page link may show a newer release later.	−USD 19.09 million Calculation and evidence -18957000 − 131000 USD Exact free cash flow: -19088000 USD 2019-01-01 – 2019-12-31: -18957000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2019-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: -19088000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18957000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221030511/forms-1.htm#2400541 Filing: 000149315221030511 Input fundies:CapitalExpenditure: 131000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315221030511/forms-1.htm#2403253 Filing: 000149315221030511 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 26.45 million Exact value Exact value: -26451000 USD 2020-01-01 – 2020-12-31: -26451000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2020-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: -26451000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26451000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315222008501/form10-k.htm#1533731 Filing: 000149315222008501 The citation records this snapshot. The page link may show a newer release later.	−USD 13.98 million Exact value Exact value: -13979000 USD 2020-01-01 – 2020-12-31: -13979000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2020-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -13979000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13979000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315222008501/form10-k.htm#1555992 Filing: 000149315222008501 The citation records this snapshot. The page link may show a newer release later.	USD 1.58 million Exact value Exact value: 1575000 USD 2020-01-01 – 2020-12-31: 1575000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2020-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 1575000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1575000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315222008501/form10-k.htm#1557869 Filing: 000149315222008501 The citation records this snapshot. The page link may show a newer release later.	−USD 15.55 million Calculation and evidence -13979000 − 1575000 USD Exact free cash flow: -15554000 USD 2020-01-01 – 2020-12-31: -13979000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1575000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2020-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: -15554000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13979000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315222008501/form10-k.htm#1555992 Filing: 000149315222008501 Input fundies:CapitalExpenditure: 1575000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315222008501/form10-k.htm#1557869 Filing: 000149315222008501 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 14.94 million Exact value Exact value: -14943000 USD 2021-01-01 – 2021-12-31: -14943000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2021-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: -14943000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14943000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315223009106/form10-k.htm#1406724 Filing: 000149315223009106 The citation records this snapshot. The page link may show a newer release later.	−USD 8.72 million Exact value Exact value: -8719000 USD 2021-01-01 – 2021-12-31: -8719000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2021-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -8719000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8719000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315223009106/form10-k.htm#1427599 Filing: 000149315223009106 The citation records this snapshot. The page link may show a newer release later.	USD 354,000 Exact value Exact value: 354000 USD 2021-01-01 – 2021-12-31: 354000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2021-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 354000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 354000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315223009106/form10-k.htm#1430271 Filing: 000149315223009106 The citation records this snapshot. The page link may show a newer release later.	−USD 9.07 million Calculation and evidence -8719000 − 354000 USD Exact free cash flow: -9073000 USD 2021-01-01 – 2021-12-31: -8719000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 354000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2021-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: -9073000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8719000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315223009106/form10-k.htm#1427599 Filing: 000149315223009106 Input fundies:CapitalExpenditure: 354000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315223009106/form10-k.htm#1430271 Filing: 000149315223009106 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 21.96 million Exact value Exact value: -21958000 USD 2022-01-01 – 2022-12-31: -21958000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2022-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: -21958000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21958000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315224012464/form10-k.htm#1446571 Filing: 000149315224012464 The citation records this snapshot. The page link may show a newer release later.	−USD 7.69 million Exact value Exact value: -7692000 USD 2022-01-01 – 2022-12-31: -7692000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2022-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: -7692000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7692000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315224012464/form10-k.htm#1493297 Filing: 000149315224012464 The citation records this snapshot. The page link may show a newer release later.	USD 322,000 Exact value Exact value: 322000 USD 2022-01-01 – 2022-12-31: 322000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2022-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 322000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 322000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315224012464/form10-k.htm#1501062 Filing: 000149315224012464 The citation records this snapshot. The page link may show a newer release later.	−USD 8.01 million Calculation and evidence -7692000 − 322000 USD Exact free cash flow: -8014000 USD 2022-01-01 – 2022-12-31: -7692000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 322000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2022-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: -8014000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7692000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315224012464/form10-k.htm#1493297 Filing: 000149315224012464 Input fundies:CapitalExpenditure: 322000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315224012464/form10-k.htm#1501062 Filing: 000149315224012464 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 1.95 million Exact value Exact value: 1954000 USD 2023-01-01 – 2023-12-31: 1954000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2023-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: 1954000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1954000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000164117225001686/form10-k.htm#1632357 Filing: 000164117225001686 The citation records this snapshot. The page link may show a newer release later.	USD 3.79 million Exact value Exact value: 3789000 USD 2023-01-01 – 2023-12-31: 3789000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2023-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: 3789000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3789000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000164117225001686/form10-k.htm#1653738 Filing: 000164117225001686 The citation records this snapshot. The page link may show a newer release later.	USD 470,000 Exact value Exact value: 470000 USD 2023-01-01 – 2023-12-31: 470000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2023-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 470000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 470000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000164117225001686/form10-k.htm#1657793 Filing: 000164117225001686 The citation records this snapshot. The page link may show a newer release later.	USD 3.32 million Calculation and evidence 3789000 − 470000 USD Exact free cash flow: 3319000 USD 2023-01-01 – 2023-12-31: 3789000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 470000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2023-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: 3319000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3789000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000164117225001686/form10-k.htm#1653738 Filing: 000164117225001686 Input fundies:CapitalExpenditure: 470000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000164117225001686/form10-k.htm#1657793 Filing: 000164117225001686 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 6.7 million Exact value Exact value: 6702000 USD 2024-01-01 – 2024-12-31: 6702000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2024-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: 6702000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6702000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#934036 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.	USD 4.65 million Exact value Exact value: 4646000 USD 2024-01-01 – 2024-12-31: 4646000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2024-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: 4646000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4646000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#953826 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.	USD 876,000 Exact value Exact value: 876000 USD 2024-01-01 – 2024-12-31: 876000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2024-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 876000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 876000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#956431 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.	USD 3.77 million Calculation and evidence 4646000 − 876000 USD Exact free cash flow: 3770000 USD 2024-01-01 – 2024-12-31: 4646000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 876000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2024-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: 3770000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4646000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#953826 Filing: 000149315226013646 Input fundies:CapitalExpenditure: 876000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#956431 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 24.58 million Exact value Exact value: 24575000 USD 2025-01-01 – 2025-12-31: 24575000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Net Income: 24575000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 24575000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#933597 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.	USD 5.83 million Exact value Exact value: 5831000 USD 2025-01-01 – 2025-12-31: 5831000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Operating Cash Flow: 5831000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5831000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#953293 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.	USD 356,000 Exact value Exact value: 356000 USD 2025-01-01 – 2025-12-31: 356000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Capital Expenditure: 356000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 356000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#955904 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.	USD 5.48 million Calculation and evidence 5831000 − 356000 USD Exact free cash flow: 5475000 USD 2025-01-01 – 2025-12-31: 5831000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 356000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERPACE BIOSCIENCES, INC. · 2025-12-31 INTERPACE BIOSCIENCES, INC. (edgar:1054102) Free cash flow: 5475000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1054102?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5831000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#953293 Filing: 000149315226013646 Input fundies:CapitalExpenditure: 356000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1054102/000149315226013646/form10-k.htm#955904 Filing: 000149315226013646 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

179 filings · 5,600 latest values · 5,600 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001054102, 1054102, IDXG, edgar:1054102, idxg

Also known as INTERPACE BIOSCIENCES, INC., Interpace Biosciences, Inc., Interpace Biosciences, Inc., Interpace Biosciences, Inc., Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC

INTERPACE BIOSCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation